SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-661038
Filing Date
2016-07-28
Accepted
2016-07-28 07:02:09
Documents
75
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d196712d10q.htm 10-Q 507334
2 EX-10.42 d196712dex1042.htm EX-10.42 266988
3 EX-10.43 d196712dex1043.htm EX-10.43 26420
4 EX-10.44 d196712dex1044.htm EX-10.44 161028
5 EX-31.1 d196712dex311.htm EX-31.1 8882
6 EX-31.2 d196712dex312.htm EX-31.2 8961
7 EX-32.1 d196712dex321.htm EX-32.1 4909
14 GRAPHIC g196712g0727015140757.jpg GRAPHIC 67415
  Complete submission text file 0001193125-16-661038.txt   4396689

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vnda-20160630.xml EX-101.INS 634148
9 XBRL TAXONOMY EXTENSION SCHEMA vnda-20160630.xsd EX-101.SCH 54673
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20160630_cal.xml EX-101.CAL 65524
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20160630_def.xml EX-101.DEF 305304
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20160630_lab.xml EX-101.LAB 400246
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20160630_pre.xml EX-101.PRE 363154
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 161788307
SIC: 2834 Pharmaceutical Preparations